Holt Capital Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5M Sell
132,987
-1,260
-0.9% -$194K 2.63% 10
2025
Q4
$20.8M Buy
134,247
+7,253
+6% +$1.09M 2.79% 10
2025
Q3
$17.7M Sell
126,994
-911
-0.7% -$123K 2.84% 9
2025
Q2
$17.2M Sell
127,905
-6,081
-5% -$821K 2.97% 8
2025
Q1
$19.6M Buy
133,986
+1,661
+1% +$241K 2.99% 10
2024
Q4
$18.2M Sell
132,325
-4,291
-3% -$628K 2.75% 10
2024
Q3
$21M Buy
136,616
+7,618
+6% +$1.15M 3.2% 10
2024
Q2
$18.8M Sell
128,998
-10,532
-8% -$1.51M 4.01% 8
2024
Q1
$20.6M Sell
139,530
-1,029
-0.7% -$148K 3.4% 9
2023
Q4
$19.2M Sell
140,559
-45
-0% -$5.85K 3.43% 8
2023
Q3
$18.1M Sell
140,604
-2,758
-2% -$366K 3.55% 8
2023
Q2
$19M Buy
143,362
+4,512
+3% +$595K 3.6% 8
2023
Q1
$18M Buy
138,850
+650
+0.5% +$84.9K 3.59% 7
2022
Q4
$18.8M Buy
138,200
+12,935
+10% +$1.71M 3.79% 6
2022
Q3
$15.2M Sell
125,265
-5,822
-4% -$750K 4.53% 5
2022
Q2
$16.8M Buy
131,087
+5,314
+4% +$697K 3.51% 7
2022
Q1
$17.2M Buy
125,773
+2,984
+2% +$395K 3.12% 10
2021
Q4
$17.3M Buy
122,789
+2,771
+2% +$368K 3.04% 10
2021
Q3
$15.3M Buy
120,018
+5,091
+4% +$673K 2.91% 11
2021
Q2
$14.5M Buy
114,927
+4,324
+4% +$530K 2.78% 11
2021
Q1
$12.9M Buy
110,603
+10,449
+10% +$1.21M 2.65% 12
2020
Q4
$11.4M Buy
100,154
+5,588
+6% +$610K 2.57% 12
2020
Q3
$9.97M Buy
94,566
+1,230
+1% +$129K 2.61% 11
2020
Q2
$9.34M Buy
93,336
+8,729
+10% +$862K 2.59% 13
2020
Q1
$7.49M Buy
84,607
+5,970
+8% +$580K 2.45% 13
2019
Q4
$8.01M Buy
78,637
+8,052
+11% +$774K 1.99% 16
2019
Q3
$6.36M Buy
70,585
+7,450
+12% +$680K 1.74% 17
2019
Q2
$5.85M Buy
63,135
+5,185
+9% +$466K 1.65% 16
2019
Q1
$5.32M Buy
57,950
+5,003
+9% +$451K 1.54% 18
2018
Q4
$4.58M Buy
52,947
+4,125
+8% +$373K 1.47% 19
2018
Q3
$4.64M Buy
48,822
+6,315
+15% +$571K 1.31% 20
2018
Q2
$3.55M Buy
42,507
+3,462
+9% +$287K 1.06% 22
2018
Q1
$3.18M Buy
39,045
+4,260
+12% +$363K 0.97% 25
2017
Q4
$2.88M Buy
34,785
+2,665
+8% +$220K 0.91% 26
2017
Q3
$2.63M Buy
32,120
+2,940
+10% +$236K 0.86% 28
2017
Q2
$2.31M Buy
29,180
+4,150
+17% +$316K 0.8% 29
2017
Q1
$1.86M Buy
25,030
+305
+1% +$22.2K 0.65% 35
2016
Q4
$1.71M Buy
24,725
+1,100
+5% +$76.4K 0.63% 38
2016
Q3
$1.7M Sell
23,625
-295
-1% -$21.7K 0.67% 32
2016
Q2
$1.72M Buy
23,920
+8,090
+51% +$570K 0.7% 32
2016
Q1
$1.07M Buy
15,830
+1,750
+12% +$117K 0.47% 46
2015
Q4
$1.01M Sell
14,080
-75
-0.5% -$5.3K 0.46% 49
2015
Q3
$937K Buy
14,155
+3,400
+32% +$248K 0.39% 50
2015
Q2
$800K Buy
10,755
+2,305
+27% +$171K 0.32% 60
2015
Q1
$613K Buy
8,450
+251
+3% +$17.9K 0.25% 75
2014
Q4
$561K Buy
8,199
+175
+2% +$11.7K 0.24% 73
2014
Q3
$513K Buy
8,024
+425
+6% +$26.6K 0.23% 79
2014
Q2
$462K Buy
7,599
+950
+14% +$55.8K 0.25% 58
2014
Q1
$389K Buy
6,649
+300
+5% +$17.3K 0.22% 59
2013
Q4
$352K Buy
+6,349
New +$340K 0.22% 56

Other funds holding XLV